Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ras oncogenes and their downstream targets.

Krishnaraj Rajalingam1, Ralf Schreck, Ulf R Rapp

  • 1University of Würzburg, Institut für Medizinische Strahlenkunde und Zellforschung, Versbacherstr. 5, D-97078 Würzburg, Germany.

Biochimica Et Biophysica Acta
|April 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MYB-related transcription factor MYPOP acts as a selective regulator of cancer cell growth.

Communications biology·2026
Same author

Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia.

Nature communications·2025
Same author

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

iScience·2025
Same author

Unveiling IRF4-steered regulation of context-dependent effector programs in CD4<sup>+</sup> T cells under Th17- and Treg-skewing conditions.

Cell reports·2025
Same author

Integrate and conquer: pan-cancer proteogenomics uncovers cancer vulnerabilities and therapeutic opportunities.

Signal transduction and targeted therapy·2024
Same author

Atypical MAPKs in cancer.

The FEBS journal·2024

RAS proteins, key regulators of cell signaling, are crucial in cancer. This review covers RAS evolution, activation, effector pathways, and therapeutic strategies targeting RAS mutations.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • RAS proteins are small GTPases regulating diverse cellular processes.
  • RAS oncogenes and their mutations are frequently found in human tumors, driving intense research.
  • Understanding RAS signaling is critical for cancer biology and therapy.

Purpose of the Study:

  • To review the biochemical properties and evolutionary history of RAS signaling.
  • To provide an overview of RAS isoform activation and effector pathways.
  • To summarize current therapeutic strategies targeting aberrant RAS signaling.

Main Methods:

  • Literature review and synthesis of existing research on RAS proteins.
  • Analysis of evolutionary pathways of RAS signaling.

Related Experiment Videos

  • Discussion of molecular mechanisms and therapeutic interventions.

    • Main Results:

    • RAS proteins are central to numerous signaling cascades.
    • Aberrant RAS signaling contributes to cancer development and progression.
    • Various strategies are being developed to target RAS pathways therapeutically.

    Conclusions:

    • RAS signaling is a fundamental pathway in cell physiology and disease.
    • Targeting RAS offers a promising avenue for cancer treatment.
    • Future research includes microRNA modulation, stem cell roles, and network analyses.